Platform Technology Designation A Gene Therapy Opportunity, OTP Director Verdun Says

 
• By Derrick Gingery

The new designation could streamline development of multiple products that use the same backbone, said Nicole Verdun, director of the US FDA’s Office of Therapeutic Products.

train platform
The new platform technology designation program eventually could help multiple sponsors developing gene therapies with the same backbone. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies